Germany suspended the use of AstraZeneca Plc’s Covid-19 vaccine amid a growing health scare that’s creating yet another delay for the European Union’s inoculation campaign.

The country cited the recommendation of the Paul Ehrlich Institute, which oversees vaccine safety, according to a statement from the health ministry on Monday.

Germany joins about a dozen places, including Northern Italy, the Netherlands and Ireland, that have halted use of the product amid reports of serious blood clotting. It’s yet another blow to a vaccination campaign that’s proving embarrassingly slow and politically damaging for governments across the EU.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook